Takeda Pharmaceutical Co. Ltd., 10% Owner at Translate Bio, Inc. (TBIO), sold 13,649,984 shares at $20.68 ($282.3M) on 2020-06-30, disclosed to the SEC on 2020-06-30.
Open-market sale of $282.3M TBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.68 | 6,824,992 | $141.1M | 50.0% |
| 2 | $20.68 | 6,824,992 | $141.1M | 50.0% |
| Total | $20.68 avg | 13,649,984 | $282.3M | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |